Literature DB >> 8135350

Spectrophotometric substrates for cytosolic epoxide hydrolase.

E C Dietze1, E Kuwano, B D Hammock.   

Abstract

In this study, we demonstrate the utility of a broad class of spectrophotometric substrates for the assay of cytosolic epoxide hydrolase purified from murine liver. These substrates, epoxy esters or carbonates, cyclize spontaneously upon or during hydrolysis of the epoxide functionality. The alcohol released by cyclization may then be assayed directly or by coupling to a second reaction. The alcohol produced, or its secondary reaction products, can be selected to give an absorption in the visible or near-uv range of the spectrum. This allows the synthesis of a wide variety of useful spectrophotometric substrates. 4-Nitrophenyl (2S,3S)-2,3-epoxy-3-phenylpropyl carbonate, at pH 6.4 and 25 degrees C, had a Vmax of 22 mumol min-1 mg-1 and a Km of 16 microM when assayed with a conventional spectrophotometer. When assayed under the same conditions with a 96-well plate reader, the measured Vmax was 15 mumol min-1 mg-1 and the Km was 6.6 microM. Some of these compounds were also found to be substrates for glutathione S-transferase, microsomal epoxide hydrolase, and porcine liver carboxylesterase. Indeed, 4-nitrophenyl 3,4-epoxy-3-phenylbutanoate was a 3.4-fold better substrate for porcine liver carboxylesterase than 4-nitrophenyl acetate when initial rates of hydrolysis were measured under the same conditions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8135350     DOI: 10.1006/abio.1994.1023

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  17 in total

Review 1.  Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications.

Authors:  Hong C Shen; Bruce D Hammock
Journal:  J Med Chem       Date:  2012-01-17       Impact factor: 7.446

2.  Fluorescent substrates for soluble epoxide hydrolase and application to inhibition studies.

Authors:  Paul D Jones; Nicola M Wolf; Christophe Morisseau; Paul Whetstone; Bertold Hock; Bruce D Hammock
Journal:  Anal Biochem       Date:  2005-08-01       Impact factor: 3.365

3.  Development of a high-throughput screen for soluble epoxide hydrolase inhibition.

Authors:  Nicola M Wolf; Christophe Morisseau; Paul D Jones; Bertold Hock; Bruce D Hammock
Journal:  Anal Biochem       Date:  2006-05-11       Impact factor: 3.365

4.  Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase.

Authors:  In-Hae Kim; Kosuke Nishi; Hsing-Ju Tsai; Tanya Bradford; Yasuko Koda; Takaho Watanabe; Christophe Morisseau; Joanne Blanchfield; Istvan Toth; Bruce D Hammock
Journal:  Bioorg Med Chem       Date:  2006-09-29       Impact factor: 3.641

5.  Lipid sulfates and sulfonates are allosteric competitive inhibitors of the N-terminal phosphatase activity of the mammalian soluble epoxide hydrolase.

Authors:  Katherine L Tran; Pavel A Aronov; Hiromasa Tanaka; John W Newman; Bruce D Hammock; Christophe Morisseau
Journal:  Biochemistry       Date:  2005-09-13       Impact factor: 3.162

6.  Cloning and characterization of a microsomal epoxide hydrolase from Heliothis virescens.

Authors:  Shizuo G Kamita; Kohji Yamamoto; Mary M Dadala; Khavong Pha; Christophe Morisseau; Aurélie Escaich; Bruce D Hammock
Journal:  Insect Biochem Mol Biol       Date:  2012-12-28       Impact factor: 4.714

7.  The 5-substituted piperazine as a novel secondary pharmacophore greatly improving the physical properties of urea-based inhibitors of soluble epoxide hydrolase.

Authors:  Hui-Yuan Li; Yi Jin; Christophe Morisseau; Bruce D Hammock; Ya-Qiu Long
Journal:  Bioorg Med Chem       Date:  2006-06-19       Impact factor: 3.641

8.  Optimization of amide-based inhibitors of soluble epoxide hydrolase with improved water solubility.

Authors:  In-Hae Kim; Fenton R Heirtzler; Christophe Morisseau; Kosuke Nishi; Hsing-Ju Tsai; Bruce D Hammock
Journal:  J Med Chem       Date:  2005-05-19       Impact factor: 7.446

9.  Crystal structure of the cystic fibrosis transmembrane conductance regulator inhibitory factor Cif reveals novel active-site features of an epoxide hydrolase virulence factor.

Authors:  Christopher D Bahl; Christophe Morisseau; Jennifer M Bomberger; Bruce A Stanton; Bruce D Hammock; George A O'Toole; Dean R Madden
Journal:  J Bacteriol       Date:  2010-01-29       Impact factor: 3.490

10.  Tryptophan fluorescence quenching by enzyme inhibitors as a tool for enzyme active site structure investigation: epoxide hydrolase.

Authors:  Evgenia G Matveeva; Christophe Morisseau; Marvin H Goodrow; Chris Mullin; Bruce D Hammock
Journal:  Curr Pharm Biotechnol       Date:  2009-09-01       Impact factor: 2.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.